FOCL
EDAP TMS S.A. American Depositary Shares
NASDAQ · Healthcare · Medical - Specialties · FR
$4.15
−0.48%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 69.1M | 70.7M | 69.4M | 65.3M | 57.9M |
| Cost of Revenue | 37.4M | 40.7M | 40.6M | 38.9M | 32.5M |
| Gross Profit | 31.8M | 30.1M | 28.7M | 26.4M | 25.4M |
| Operating Expenses | |||||
| R&D Expense | 9.5M | 10.1M | 9.1M | 8.2M | 6.0M |
| SG&A Expense | 49.5M | 45.2M | 42.6M | 40.3M | 24.7M |
| General & Admin Expense | — | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 59.0M | 55.3M | 51.7M | 48.5M | 30.8M |
| Cost and Expenses | 96.3M | 96.0M | 92.3M | 87.4M | 63.3M |
| Operating Income (EBIT) | (27.2M) | (25.2M) | (23.0M) | (22.1M) | (5.3M) |
| Non-Operating | |||||
| Interest Income | — | 252.8K | 861.0K | 1.4M | 424.6K |
| Interest Expense | 5.5M | 791.4K | 255.3K | 250.8K | 176.6K |
| Net Interest Income | (5.5M) | (538.7K) | 605.7K | 1.2M | 248.0K |
| Other Non-Op Income/Expense | (11.3M) | (4.1M) | 2.2M | (539.5K) | 2.5M |
| Non-Operating Income (excl Interest) | 145.4K | 3.3M | (2.5M) | 288.7K | (2.7M) |
| EBT (Pre-Tax Income) | (38.5M) | (29.3M) | (20.8M) | (22.6M) | (2.8M) |
| Income Tax Expense | 338.8K | 71.2K | (183.0K) | 252.7K | 269.0K |
| Bottom Line | |||||
| Net Income | (38.9M) | (29.3M) | (20.6M) | (22.9M) | (3.1M) |
| Earnings from Cont. Ops | (38.8M) | (29.3M) | (20.6M) | (22.9M) | (3.1M) |
| Earnings from Discont. Ops | (74.9K) | — | — | — | — |
| Bottom Line Net Income | (38.9M) | (29.3M) | (20.6M) | (22.9M) | (3.1M) |
| Per Share | |||||
| Basic EPS | ($1.04) | ($0.78) | ($0.55) | ($0.62) | ($0.09) |
| Diluted EPS | ($1.04) | ($0.78) | ($0.55) | ($0.62) | ($0.09) |
| Revenue Per Share | $1.84 | $1.89 | $1.86 | $1.77 | $1.68 |
| Shares | |||||
| Basic Shares Outstanding | 37.5M | 37.4M | 37.3M | 37.0M | 34.4M |
| Diluted Shares Outstanding | 37.5M | 37.4M | 37.3M | 37.0M | 34.4M |
| Profitability Metrics | |||||
| EBITDA | (26.4M) | (25.0M) | (17.7M) | (20.3M) | (915.4K) |
| D&A | 899.3K | 3.4M | 2.8M | 2.1M | 1.7M |
| EBIT | (27.3M) | (28.5M) | (20.5M) | (22.4M) | (2.6M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026